BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6445105)

  • 21. Prolongation of allograft survival by cyclosporin A.
    Cosimi AB; Shield CF; Peters C; Burton RC; Scott G; Russell PS
    Surg Forum; 1979; 30():287-9. PubMed ID: 120019
    [No Abstract]   [Full Text] [Related]  

  • 22. Reversible suppression of allo-antibody production by cyclosporin A.
    Denham S; Styles JM; Barfoot RK; Dean CJ
    Int Arch Allergy Appl Immunol; 1980; 62(4):453-8. PubMed ID: 6991444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts.
    Homan WP; Fabre JW; Williams KA; Millard PR; Morris PJ
    Transplantation; 1980 May; 29(5):361-6. PubMed ID: 6990560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporin a can abrogate the sensitizing effect of blood transfusion in rats without interfering with its beneficial influence.
    Marquet RL; Heystek GA
    Transplantation; 1981 May; 31(5):396-7. PubMed ID: 7015629
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunosuppression for organ grafting.
    Calne RY
    Int J Immunopharmacol; 1979; 1(3):163-4. PubMed ID: 399478
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanisms of cardiac allograft prolongation by cyclosporin-A.
    Hutchinson IF; Shadur CA; Duarte A; Baldwin WM; Strom TB; Tilney NL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):412-3. PubMed ID: 6455797
    [No Abstract]   [Full Text] [Related]  

  • 27. Absence of the beneficial effect of blood transfusions in canine renal allograft recipients treated with low-dose cyclosporin A.
    Niessen GJ; Obertop H; Bijnen AB; Joling P
    Transplantation; 1981 Jun; 31(6):480-1. PubMed ID: 7020182
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclosporin A.
    Lancet; 1979 Oct; 2(8146):779-80. PubMed ID: 90866
    [No Abstract]   [Full Text] [Related]  

  • 29. Orthotopic heart and combined heart and lung transplantation with cyclosporin-A immune suppression.
    Reitz BA; Bieber CP; Raney AA; Pennock JL; Jamieson SW; Oyer PE; Stinson EB
    Transplant Proc; 1981 Mar; 13(1 Pt 1):393-6. PubMed ID: 6791329
    [No Abstract]   [Full Text] [Related]  

  • 30. Properties of cyclosporin--A-induced graft acceptance.
    White DJ; Timmerman W; Davies HS; Nagao T; Kasahara K; Plumb A
    Transplant Proc; 1981 Mar; 13(1 Pt 1):379-82. PubMed ID: 7022857
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of cyclosporin A in rat kidney grafts.
    Simms MH; Cruickshank JK; Blainey JD; Cameron AH; Barnes AD
    Transplant Proc; 1980 Jun; 12(2):256-60. PubMed ID: 6994293
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclosporin-A: effect on marrow engraftment and graft-versus-host disease in dogs.
    Deeg HJ; Storb R; Weiden PL; Graham T; Atkinson K; Thomas ED
    Transplant Proc; 1981 Mar; 13(1 Pt 1):402-4. PubMed ID: 7022862
    [No Abstract]   [Full Text] [Related]  

  • 33. Interaction of cyclosporin A with antilymphocyte serum and with enhancing serum for the suppression of renal allograft rejection in the rat.
    Homan WP; Fabre JW; Millard PR; Morris PJ
    Transplantation; 1980 Mar; 29(3):219-22. PubMed ID: 6987786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cyclosporin A on immunological recovery after bone marrow transplantation.
    von Fliedner VE; Gratwohl A; Jeannet M; Nissen C; Speck B
    Lancet; 1981 Feb; 1(8217):439. PubMed ID: 6110062
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of specific tolerance in rabbits by kidney allografting and short periods of cyclosporin-A treatment.
    Green CJ; Allison AC; Precious S
    Lancet; 1979 Jul; 2(8134):123-5. PubMed ID: 88557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged survival of corneal allografts in rabbits treated with cyclosporin A.
    Coster DJ; Shepherd WF; Fook TC; Rice NS; Jones BR
    Lancet; 1979 Sep; 2(8144):688-9. PubMed ID: 90771
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclosporin A in clinical kidney grafting from cadaver donors.
    Calne RY; White DJ; Thiru S; Evans DB; McMaster P; Dunn DC; Craddock GN; Rolles K
    Proc Eur Dial Transplant Assoc; 1979; 16():305-9. PubMed ID: 398499
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of various methods of chemical immunosuppression in islet cell transplantation.
    Bell PR; Wood RF; Peters M; Nash JR
    Transplant Proc; 1980 Jun; 12(2):291-3. PubMed ID: 6249004
    [No Abstract]   [Full Text] [Related]  

  • 39. New techniques for selective immune suppression increase transplant odds.
    Maugh TA
    Science; 1980 Oct; 210(4465):44-6. PubMed ID: 6774417
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased efficacy of cyclosporin A with splenectomy prolonging the survival of rat heart allografts.
    Downing TP; Reitz BA; Stinson EB; Aziz S; Shumway N
    Transplantation; 1981 Jul; 32(1):76-7. PubMed ID: 7022803
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.